In the TCGA dataset, all patients with ESCC received surgical intervention for localized disease, and were enrolled in the era when anti-PD-1 ICIs were unavailable for human cancer treatment (26). This evidence concerns the gene PDCD1 and esophageal squamous cell carcinoma.